<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:media="http://search.yahoo.com/mrss/"><channel><title>Zibb.com: Invitrogen Corporation (Industry News &amp; Blogs)</title><link>http://www.zibb.com/all/theme/cq/Invitrogen+Corporation</link><atom:link rel="self" type="application/rss+xml" href="http://www.zibb.com/all/theme/cq/Invitrogen+Corporation" /><description>
					Zibb. The Global business search engine.
				</description><language>
					en-US
				</language><webMaster>search@zibb.com (RB Search)</webMaster><copyright>Copyright (c) 2007 Reed Business Information. All rights reserved.</copyright><pubDate>Sat, 03 Oct 2009 02:51:03 GMT</pubDate><lastBuildDate>Sat, 03 Oct 2009 02:51:03 GMT</lastBuildDate><ttl>60</ttl><image><title>Zibb.com: Invitrogen Corporation (Industry News &amp; Blogs)
          </title><width>88</width><height>31</height><link>http://www.zibb.com/all/theme/cq/Invitrogen+Corporation</link><url>
						http://www.zibb.com/images/en/g_zibb_logo_beta.gif
					</url></image><item><title>Cyclin I activates Cdk5 and regulates expression of Bcl-2 and Bcl...
      </title><link>http://www.jci.org/articles/view/37978</link><description>Cyclin I is an atypical cyclin because it is most abundant in postmitotic cells. We previously showed that cyclin I does not regulate proliferation, but rather controls survival of podocytes, terminally differentiated epithelial cells that are essential for the structural and functional integrity</description><guid>http://www.jci.org/articles/view/37978</guid><category domain="http://www.zibb.com">Invitrogen Corporation</category><pubDate>Sat, 03 Oct 2009 02:51:03 GMT</pubDate><source url="http://www.jci.org" /></item><item><title>Invitrogen unveils Plexmark 3 renal biomarker tool</title><link>http://www.laboratorytalk.com/news/inw/inw178.html</link><description>Invitrogen, part of Life Technologies Corporation, has announced the availability of a biomarker tool for use in pre-clinical research into kidney function.</description><guid>http://www.laboratorytalk.com/news/inw/inw178.html</guid><category domain="http://www.zibb.com">Invitrogen Corporation</category><pubDate>Wed, 05 Aug 2009 08:00:00 GMT</pubDate><source url="http://www.laboratorytalk.com" /></item><item><title>Invitrogen Launches Online Resource for Cellular Technologies</title><link>http://www.pharmaasia.com/article-7843-invitrogenlaunchesonlineresourceforcellulartechnologies-asia.html</link><description>Invitrogen has launched a comprehensive online resource for cell biology information and technology.</description><guid>http://www.pharmaasia.com/article-7843-invitrogenlaunchesonlineresourceforcellulartechnologies-asia.html</guid><category domain="http://www.zibb.com">Invitrogen Corporation</category><pubDate>Fri, 17 Jul 2009 00:00:00 GMT</pubDate><source url="http://www.pharmaasia.com" /></item><item><title>Invitrogen Corporation Launches Life Science Industry's First Com...
      </title><link>http://www.biospace.com/news_story.aspx?StoryID=149020&amp;full=1</link><description>CARLSBAD, Calif.--(BUSINESS WIRE)--Invitrogen, part of Life Technologies Corporation (NASDAQ:LIFE), today announced the launch of the life-science industrys first comprehensive online resource for cell biology information and technology. The Invitrogen Cell Resource Center is a Web portal that</description><guid>http://www.biospace.com/news_story.aspx?StoryID=149020&amp;full=1</guid><category domain="http://www.zibb.com">Invitrogen Corporation</category><pubDate>Tue, 07 Jul 2009 12:00:00 GMT</pubDate><source url="http://www.biospace.com" /></item><item><title>Graham Packaging's Teamwork with Invitrogen Leads to an Award-Win...
      </title><link>http://news.prnewswire.com/ViewContent.aspx?ACCT=109&amp;STORY=/www/story/03-26-2009/0004995614&amp;EDATE=</link><description>The GIBCO(R) bottle that Graham Packaging produces for Invitrogen is a new cell culture media sterile container designed to improve the efficiency of storage and the ease of use. The bottle won an award for medical packaging in the 2008/2009 AmeriStar competition.</description><guid>http://news.prnewswire.com/ViewContent.aspx?ACCT=109&amp;STORY=/www/story/03-26-2009/0004995614&amp;EDATE=</guid><category domain="http://www.zibb.com">Invitrogen Corporation</category><pubDate>Thu, 26 Mar 2009 20:37:00 GMT</pubDate><source url="http://news.prnewswire.com" /></item><item><title>Frost &amp; Sullivan Recognizes Life Technologies for Excellence in t...
      </title><link>http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&amp;docid=162691224</link><description>Based on its recent analysis of the drug discovery technologies market, Frost &amp; Sullivan recognizes Life Technologies with the 2009 North American Frost &amp; Sullivan Company of the Year Award. The company's size, product portfolio breadth, market segment leadership, and strong future potential set it</description><guid>http://www.frost.com/prod/servlet/press-release.pag?Src=RSS&amp;docid=162691224</guid><category domain="http://www.zibb.com">Invitrogen Corporation</category><pubDate>Tue, 24 Mar 2009 00:00:00 GMT</pubDate><source url="http://www.frost.com" /></item><item><title>"Good Cause" Not Shown for Transfer to Michigan</title><link>http://mcsmith.blogs.com/eastern_district_of_texas/2009/02/good-cause-not-shown-for-transfer-to-michigan.html</link><description>MHL TEK, LLC v. Nissan Motor Co. et al (2-07-cv-00289) (E.D. Tex. Feb. 23, 2009) Judge: T. John Ward In this case Judge Ward was asked to reconsider his decision of September 10, 2008 (pre VW Tech) denying the defendants'...</description><guid>http://mcsmith.blogs.com/eastern_district_of_texas/2009/02/good-cause-not-shown-for-transfer-to-michigan.html</guid><category domain="http://www.zibb.com">Invitrogen Corporation</category><pubDate>Wed, 25 Feb 2009 16:32:21 GMT</pubDate><source url="http://mcsmith.blogs.com" /></item><item><title>Paladin Labs to Distribute GSK’s Dexedrine in Canada</title><link>http://www.genengnews.com/news/bnitem.aspx?name=46438512</link><description>Paladin Labs to Distribute GSK’s Dexedrine in Canada. Genetic Engineering &amp; Biotechnology News - Biotechnology from Bench to Business. The Leading Publication in Biotechnology. Genetic Engineering News is the most widely read bioindustry publication worldwide and has long been acknowledged as the</description><guid>http://www.genengnews.com/news/bnitem.aspx?name=46438512</guid><category domain="http://www.zibb.com">Invitrogen Corporation</category><pubDate>Mon, 01 Dec 2008 00:00:00 GMT</pubDate><source url="http://www.genengnews.com" /></item><item><title>Invitrogen and Applied Biosystems Announce Successful Completion ...
      </title><link>http://www.nanowerk.com/news/newsid=8368.php</link><description>This is an exciting time in the history of Invitrogen and Applied Biosystems, said Greg Lucier, Chairman and Chief Executive Officer of Life Technologies.</description><guid>http://www.nanowerk.com/news/newsid=8368.php</guid><category domain="http://www.zibb.com">Invitrogen Corporation</category><pubDate>Wed, 26 Nov 2008 07:26:23 GMT</pubDate><source url="http://www.nanowerk.com" /></item><item><title>Boning Up on Amgen's D-mab for Osteoporosis</title><link>http://seekingalpha.com/article/104880-boning-up-on-amgen-s-d-mab-for-osteoporosis?source=feed</link><description>Mike Huckman submits: While on the elliptical at the gym the other night I was watching one network newscast and the person on the machine next to me was watching another one. Both shows hit their commercial breaks</description><guid>http://seekingalpha.com/article/104880-boning-up-on-amgen-s-d-mab-for-osteoporosis?source=feed</guid><category domain="http://www.zibb.com">Invitrogen Corporation</category><pubDate>Sun, 09 Nov 2008 07:30:23 GMT</pubDate><source url="http://seekingalpha.com" /></item><item><title>Press Release: Invitrogen Launches Microarray to Study Non-Coding...
      </title><link>http://www.agilent.com/about/newsroom/presrel/2008/06nov-ca08072.html</link><description>Invitrogen Corp. (NASDAQ: IVGN), a provider of essential life science technologies for research, production and diagnostics, today announced the launch of the first high-density microarray for the profiling of non-coding RNAs.</description><guid>http://www.agilent.com/about/newsroom/presrel/2008/06nov-ca08072.html</guid><category domain="http://www.zibb.com">Invitrogen Corporation</category><pubDate>Thu, 06 Nov 2008 16:00:00 GMT</pubDate><source url="http://www.agilent.com" /></item><item><title>Invitrogen Will Change Name to Life Technologies</title><link>http://www.xconomy.com/san-diego/2008/11/06/invitrogen-will-change-name-to-life-technologies/</link><description>Invitrogen, the San Diego-based maker of lab products, said it plans to change its name to Life Technologies when it completes the acquisition of Foster City,</description><guid>http://www.xconomy.com/san-diego/2008/11/06/invitrogen-will-change-name-to-life-technologies/</guid><category domain="http://www.zibb.com">Invitrogen Corporation</category><pubDate>Thu, 06 Nov 2008 15:07:41 GMT</pubDate><source url="http://www.xconomy.com" /></item><item><title>How Much Vigor In Invitrogen? (IVGN, ABI, TMO)</title><link>http://community.investopedia.com/news/IA/2008/How-Much-Vigor-In-Invitrogen-IVGN-ABI-TMO1027.aspx</link><description>Invitrogen is in the right space, but does management have the right plan? &lt;a</description><guid>http://community.investopedia.com/news/IA/2008/How-Much-Vigor-In-Invitrogen-IVGN-ABI-TMO1027.aspx</guid><category domain="http://www.zibb.com">Invitrogen Corporation</category><pubDate>Mon, 27 Oct 2008 06:00:00 GMT</pubDate><source url="http://community.investopedia.com" /></item><item><title>IDEXX Laboratories Announces Third Quarter Results (PR Newswire)</title><link>http://biz.yahoo.com/prnews/081024/nef007.html?.v=73</link><description>IDEXX Laboratories Announces Third Quarter Results. - WESTBROOK, Maine, Oct. 24 /PRNewswire-FirstCall/ -- IDEXX Laboratories, Inc. (Nasdaq: IDXX - News), today reported that revenue for the third quarter of 2008 increased 9% to $251.1 million from $229.4 million for the third quarter of 2007.</description><guid>http://biz.yahoo.com/prnews/081024/nef007.html?.v=73</guid><category domain="http://www.zibb.com">Invitrogen Corporation</category><pubDate>Fri, 24 Oct 2008 11:00:00 GMT</pubDate><source url="http://biz.yahoo.com" /></item><item><title>Illuminating Illumina</title><link>http://www.fool.com/investing/general/2008/10/22/illuminating-illumina.aspx</link><description>The Motley Fool - Did they miss, meet, or beat expectations? Well, it's complicated.</description><guid>http://www.fool.com/investing/general/2008/10/22/illuminating-illumina.aspx</guid><category domain="http://www.zibb.com">Invitrogen Corporation</category><pubDate>Wed, 22 Oct 2008 20:44:06 GMT</pubDate><source url="http://www.fool.com" /></item><item><title>Invitrogen to expand on Grand Island</title><link>http://feeds.bizjournals.com/~r/vertical_26/~3/426745425/daily10.html</link><description>The life sciences research and development firm is planning a 21,500-square-foot expansion to its Staley Road plant, a move that is viewed as strengthening its local position and securing the future for the 475 people who work at the plant. The $2.</description><guid>http://feeds.bizjournals.com/~r/vertical_26/~3/426745425/daily10.html</guid><category domain="http://www.zibb.com">Invitrogen Corporation</category><pubDate>Mon, 20 Oct 2008 18:57:59 GMT</pubDate><source url="http://feeds.bizjournals.com" /></item><item><title>Combined Applied Biosystems, Invitrogen names leadership team</title><link>http://www.bizjournals.com/eastbay/stories/2008/09/15/daily58.html?ana=from_rss</link><description>Carlsbad-based Invitrogen (NASDAQ: IVGN) and Foster City-based Applied Biosystems (NYSE: ABI) said the merger is still conditional upon shareholder and European Commission approvals. In June Invitrogen said it agreed to buy Applied in a cash and stock deal the companies valued at $6.</description><guid>http://www.bizjournals.com/eastbay/stories/2008/09/15/daily58.html?ana=from_rss</guid><category domain="http://www.zibb.com">Invitrogen Corporation</category><pubDate>Wed, 17 Sep 2008 20:49:55 GMT</pubDate><source url="http://www.bizjournals.com" /></item><item><title>Focus Stock: A New Formula for Invitrogen</title><link>http://www.businessweek.com/investor/content/sep2008/pi2008098_039737.htm?campaign_id=rss_null</link><description>S&amp;P thinks Invitrogen's proposed merger with Applied Biosystems could make it a leader in life sciences, and ranks the shares strong buy.</description><guid>http://www.businessweek.com/investor/content/sep2008/pi2008098_039737.htm?campaign_id=rss_null</guid><category domain="http://www.zibb.com">Invitrogen Corporation</category><pubDate>Tue, 09 Sep 2008 04:01:00 GMT</pubDate><source url="http://www.businessweek.com" /></item><item><title>Invitrogen names new senior vice president and CIO</title><link>http://www.pharmaceutical-business-review.com/article_news.asp?guid=69B4EFC2-6E8C-4281-828A-A7317F38711F</link><description>Invitrogen, a provider of essential life science technologies for research, production and diagnostics, has appointed Joe Beery as head of its global information technology.</description><guid>http://www.pharmaceutical-business-review.com/article_news.asp?guid=69B4EFC2-6E8C-4281-828A-A7317F38711F</guid><category domain="http://www.zibb.com">Invitrogen Corporation</category><pubDate>Mon, 08 Sep 2008 14:47:00 GMT</pubDate><source url="http://www.pharmaceutical-business-review.com" /></item><item><title>Invitrogen Names Joe Beery Senior Vice President, Chief Informati...
      </title><link>http://www.smartbrief.com/news/AIA/industryBW-detail.jsp?id=4A37C24D-74D6-467F-B22A-7A56E5004E63&amp;sb_code=RSS&amp;i=Airlines</link><description>Invitrogen Names Joe Beery Senior Vice President, Chief Information Officer</description><guid>http://www.smartbrief.com/news/AIA/industryBW-detail.jsp?id=4A37C24D-74D6-467F-B22A-7A56E5004E63&amp;sb_code=RSS&amp;i=Airlines</guid><category domain="http://www.zibb.com">Invitrogen Corporation</category><pubDate>Fri, 05 Sep 2008 12:31:10 GMT</pubDate><source url="http://www.smartbrief.com" /></item><item><title>Invitrogen launches patent licensing program for random prime amp...
      </title><link>http://www.news-medical.net/?id=41194</link><description>Invitrogen Corporation today announced that it has signed non-exclusive agreements with New England Biolabs, Inc., QIAGEN GmbH, and Kirkegaard &amp; Perry Laboratories, Inc. (KPL), whereby the companies have licensed Invitrogen's patented technology covering the random prime amplification of nucleic</description><guid>http://www.news-medical.net/?id=41194</guid><category domain="http://www.zibb.com">Invitrogen Corporation</category><pubDate>Thu, 04 Sep 2008 13:06:00 GMT</pubDate><source url="http://www.news-medical.net" /></item><item><title>Invitrogen Launches Legionella Test To Streamline Surveillance</title><link>http://www.wateronline.com/article.mvc/Invitrogen-Launches-Legionella-Test-To-0001?atc~c=771+s=773+r=001+l=a&amp;VNETCOOKIE=NO</link><description>Invitrogen Launches Legionella Test To Streamline Surveillance - Invitrogen Corporation</description><guid>http://www.wateronline.com/article.mvc/Invitrogen-Launches-Legionella-Test-To-0001?atc~c=771+s=773+r=001+l=a&amp;VNETCOOKIE=NO</guid><category domain="http://www.zibb.com">Invitrogen Corporation</category><pubDate>Tue, 26 Aug 2008 08:46:33 GMT</pubDate><source url="http://www.wateronline.com" /></item><item><title>Invitrogen's 2nd-quarter profit rises 30 percent on higher sales ...
      </title><link>http://www.canadianbusiness.com/markets/headline_news/article.jsp?content=D924CJL80</link><description>CARLSBAD, Calif. (AP) - Invitrogen Corp., which makes kits that researchers use for gene cloning, said Thursday its second-quarter profit rose 30 percent on higher sales of its drug discovery and research materials. The company earned $53.</description><guid>http://www.canadianbusiness.com/markets/headline_news/article.jsp?content=D924CJL80</guid><category domain="http://www.zibb.com">Invitrogen Corporation</category><pubDate>Thu, 24 Jul 2008 19:25:00 GMT</pubDate><source url="http://www.canadianbusiness.com" /></item><item><title>An offer Genentech can't refuse?</title><link>http://www.nature.com/news/2008/080722/full/news.2008.968.html?s=news_rss</link><description>On Monday, the Swiss pharmaceutical giant Roche offered US$43.7 billion to acquire the 44% of biotechnology jewel Genentech that it doesn’t currently own.</description><guid>http://www.nature.com/news/2008/080722/full/news.2008.968.html?s=news_rss</guid><category domain="http://www.zibb.com">Invitrogen Corporation</category><pubDate>Tue, 22 Jul 2008 04:23:21 GMT</pubDate><source url="http://www.nature.com" /></item><item><title>Novell SUSE Linux beats out Red Hat on cost at life sciences firm</title><link>http://searchenterpriselinux.techtarget.com/news/article/0,289142,sid39_gci1321810,00.html?track=sy184</link><description>By standardizing on Novell SUSE Linux and VMware rather than Red Hat, Invitrogen has saved on cost and achieved better integrated VMware and Active Directory.</description><guid>http://searchenterpriselinux.techtarget.com/news/article/0,289142,sid39_gci1321810,00.html?track=sy184</guid><category domain="http://www.zibb.com">Invitrogen Corporation</category><pubDate>Mon, 21 Jul 2008 13:14:23 GMT</pubDate><source url="http://searchenterpriselinux.techtarget.com" /></item></channel></rss>